Published in PLoS One on May 26, 2015
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
Dopamine neuron systems in the brain: an update. Trends Neurosci (2007) 4.44
Normal and pathological oscillatory communication in the brain. Nat Rev Neurosci (2005) 3.72
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci (2002) 2.93
Internet-enabled high-resolution brain mapping and virtual microscopy. Neuroimage (2007) 2.75
3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature (1957) 2.67
Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci (2002) 2.38
Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci (2003) 2.31
The cerebral oscillatory network of parkinsonian resting tremor. Brain (2003) 2.22
Experimental models of Parkinson's disease. Nat Rev Neurosci (2001) 2.06
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol (2007) 1.89
Classic and new animal models of Parkinson's disease. J Biomed Biotechnol (2012) 1.45
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm (Vienna) (1996) 1.45
Animal models of Parkinson's disease. FEBS J (2012) 1.42
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol (2011) 1.39
A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med (2011) 1.36
Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord (2002) 1.34
Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol (1997) 1.30
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods (2000) 1.27
Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science (1986) 1.26
The pathophysiology of essential tremor and Parkinson's tremor. Curr Neurol Neurosci Rep (2013) 1.20
A tale on animal models of Parkinson's disease. Mov Disord (2011) 1.18
MPTP toxicity: implications for research in Parkinson's disease. Annu Rev Neurosci (1988) 1.16
Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm (Vienna) (2004) 1.15
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain (2007) 1.14
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Exp Neurol (2006) 1.12
New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain (2006) 1.12
Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience (1993) 0.98
Modeling Parkinson's disease in monkeys for translational studies, a critical analysis. Exp Neurol (2013) 0.94
Modeling Parkinson's disease in primates: The MPTP model. Cold Spring Harb Perspect Med (2012) 0.94
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci (2008) 0.93
Oscillating central motor networks in pathological tremors and voluntary movements. What makes the difference? Neuroimage (2012) 0.92
Primate models of Parkinson's disease. Exp Neurol (2003) 0.91
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating Scale. Mov Disord (2012) 0.86
Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease. Exp Toxicol Pathol (2012) 0.84
Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease. Med Sci Monit (2005) 0.84
The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias. Brain Res Bull (2011) 0.82
A new MRI approach for accurately implanting microelectrodes into deep brain structures of the rhesus monkey (Macaca mulatta). J Neurosci Methods (2010) 0.81
Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys. Neurobiol Dis (2012) 0.81
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. PLoS One (2014) 0.79
Intracerebral injections of isotonic saline prevent behavioral deficits from brain damage. Physiol Behav (1982) 0.78
Use of 6-hydroxydopamine to deplete brain catecholamines in the rhesus monkey: effects on urinary catecholamine metabolites and behavior. Psychopharmacology (Berl) (1981) 0.78
Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication. J Neural Transm (Vienna) (1996) 0.77
'Like a thief in the night': the selectivity of degeneration in Parkinson's disease. Brain (1999) 0.77
The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis. PLoS One (2016) 0.75